Singapore, April 27 -- The Health Sciences Authority received information related to the study titled 'A Study to Evaluate the Effect of Fasting Duration and Temporary Withholding of Tirzepatide on Re... Read More
Singapore, April 27 -- The Health Sciences Authority received information related to the study titled 'A Phase 1/2 Open-Label, Umbrella Platform Design Study of Investigational Agents in Combination W... Read More
New Delhi, April 27 -- Strikes across Ukraine, Russian-occupied territory and Russia over the past day killed at least 16 people, authorities said Sunday as the 40th anniversary of the Chernobyl nucle... Read More
India, April 27 -- Veteran actor Bharat Kapoor passed away on April 27, in Mumbai at the age of 80. According to multiple reports, he died at around 3:30pm at Sion Hospital after suffering from multip... Read More
New Delhi, April 27 -- While the Indian primary market may have cooled off due to a meltdown on Dalal Street this year, the top-performing debutants of 2025 have largely remained on a firm footing. T... Read More
India, April 27 -- Nicolas Pepe doesn't seem to stay single for long, and if the latest viral tweet is to be believed, the Villarreal winger has once again found himself in the spotlight. Known for hi... Read More
Mumbai, April 27 -- A sessions court in Maharashtra's Nashik district today refused to grant interim protection to Nida Khan, prime accused in the sexual harassment and religious coercion case at Tata... Read More
Singapore, April 27 -- The Health Sciences Authority received information related to the study titled 'A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combi... Read More
Singapore, April 27 -- The Health Sciences Authority received information related to the study titled ''Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the p... Read More
Singapore, April 27 -- The Health Sciences Authority received information related to the study titled 'IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-98650... Read More